Risperdal/Gynecomastia Trial Stopped; Defense Must Produce Study Reanalysis Data

(November 19, 2015, 1:50 PM EST) -- PHILADELPHIA — A Pennsylvania state court Risperdal gynecomastia trial was stopped Nov. 18 to allow defendants Janssen Pharmaceuticals Inc. and Johnson & Johnson time to give the plaintiff data about a...
To view the full article, register now.